The World Health Organization (WHO) on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics.
The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.
It was found to have 64 per cent efficacy against symptomatic disease and 92 per cent against severe COVID-19, the agency said.
Other vaccines that have similar clearance from the agency include those made by Pfizer and BioNTech, Moderna, AstraZeneca, Johnson & Johnson and Novavax.
Four Bahrainis arrested for spying for Iranian Guard
First train to Pyongyang in six years leaves Beijing as neighbours revive link
Six vessels attacked in Gulf, Strait of Hormuz
IEA announces record oil stockpile release over Iran war supply disruptions
UN Security Council adopts resolution condemning Iran attacks on Gulf states
Oman works to contain fire at Salalah port after drones strike
Strike hits Beirut apartment block as Israel presses attacks
Six killed in Swiss bus blaze after person reportedly sets themselves on fire
